Professor Glenn King has been working on animal venoms since 1996.He has extensive experience in the discovery, production, and structural and functional characterization of venom proteins, and is intimately aware of the issues surrounding their development as drugs and insecticides. In 2006, Professor King founded an agricultural biotechnology company, Vestaron Corporation, that is developing spider-venom peptides discovered in the lab as bioinsecticides.His current research is largely focussed on the development of venom peptides as analgesics for the treatment of chronic pain.
23 Ebooki wg David E. Thurston
David E Thurston & Paul J M Jackson: Cytotoxic Payloads for AntibodyDrug Conjugates
Antibody–drug conjugates (ADCs) represent one of the most promising and exciting areas of anticancer drug discovery. Five ADCs are now approved in the US and EU [i.e., ado-trastuzumab emtansine (Kadc …
PDF
Angielski
DRM
€239.99
Khondaker Miraz Rahman & David E Thurston: Small-molecule Transcription Factor Inhibitors in Oncology
Oncogenic transcription factors are an increasingly important target for anticancer therapies. Inhibiting these transcription factors could allow tumour cells to be 'reprogrammed’, leading to apoptos …
PDF
Angielski
DRM
€199.99
Glenn F King: Venoms to Drugs
The pharmaceutical industry has become increasingly interested in biologics from animal venoms as a potential source for therapeutic agents in recent years, with a particularly emphasis on peptides. …
EPUB
Angielski
DRM
€229.99
James D Adams & Eric J Lien: Traditional Chinese Medicine
Traditional Chinese medicine has a strong scientific basis, but the science of these important preparations is often rarely discussed. Western approaches often simplify traditional Chinese medicine t …
EPUB
Angielski
DRM
€199.99
Khondaker Miraz Rahman & David E Thurston: Small-molecule Transcription Factor Inhibitors in Oncology
Oncogenic transcription factors are an increasingly important target for anticancer therapies. Inhibiting these transcription factors could allow tumour cells to be 'reprogrammed’, leading to apoptos …
EPUB
Angielski
DRM
€199.99
David E Thurston & Paul J M Jackson: Cytotoxic Payloads for Antibody–Drug Conjugates
Antibody–drug conjugates (ADCs) represent one of the most promising and exciting areas of anticancer drug discovery. Five ADCs are now approved in the US and EU [i.e., ado-trastuzumab emtansine (Kadc …
EPUB
Angielski
DRM
€239.99
Raphael Gorodetsky & Richard Schäfer: Stem Cell-Based Tissue Repair
The need for customized stem cell therapies for specific conditions will be a major issue in the coming decades. This unique book by experts in the field reviews the subject as it stands today. Its c …
PDF
Angielski
DRM
€184.99
James D Adams & Eric J Lien: Traditional Chinese Medicine
Traditional Chinese medicine has a strong scientific basis, but the science of these important preparations is often rarely discussed. Western approaches often simplify traditional Chinese medicine t …
PDF
Angielski
DRM
€199.99
Glenn F. King: Venoms to Drugs
The pharmaceutical industry has become increasingly interested in biologics from animal venoms as a potential source for therapeutic agents in recent years, with a particularly emphasis on peptides. …
PDF
Angielski
DRM
€229.99
Martin Braddock: Biomedical Imaging
The focus of this new book is for medicinal chemists on the chemical agents that have been used, or might be required in the future, and the methods of synthesis for inserting the reporter groups. Me …
PDF
Angielski
DRM
€194.99
Danilo Milardi & Enrico Rizzarelli: Neurodegeneration
Since Alois Alzheimer described the results of his postmortem studies in 1906, significant strides have been made in understanding the pathogenesis of neurodegenerative diseases. Substantial evidence …
PDF
Angielski
DRM
€164.99
Ben Dunn: Proteinases as Drug Targets
This book provides vital information on a class of enzymes that have emerged as key drug targets in a number of human diseases, including HIV/AIDS, Hypertension, Cancer, and Alzheimer’s disease. Ther …
PDF
Angielski
DRM
€179.99
Lee Banting & Tim Clark: Drug Design Strategies
This book documents the latest research into the theory and application of force-fields, semi-empirical molecular orbital, density functional and ab initio calculations, Quantum Mechanical (QM) based …
PDF
Angielski
DRM
€184.99
James D Adams & Keith Parker: Extracellular and Intracellular Signaling
Intracellular cell signaling is a well understood process. However, extracellular signals such as hormones, adipokines, cytokines and neurotransmitters are just as important but have been largely ign …
PDF
Angielski
DRM
€179.99
Johan Wouters & Luc Quéré: Pharmaceutical Salts and Co-crystals
From crystal structure prediction to totally empirical screening, the quest for new crystal forms has become one of the most challenging issues in the solid state science and particularly in the phar …
PDF
Angielski
DRM
€194.99
Svetlana Dambinova & Ronald L Hayes: Biomarkers for Traumatic Brain Injury
Due to injuries sustained in sports and in combat, interest in TBI has never been greater. Biomarkers for Traumatic Brain Injury will fulfil a gap in our understanding of what is occurring in the bra …
PDF
Angielski
DRM
€144.99
Brian Cox & Martin Gosling: Ion Channel Drug Discovery
Ion channel drug discovery is a rapidly evolving field fuelled by recent, but significant, advances in our understanding of ion channel function combined with enabling technologies such as automated …
PDF
Angielski
DRM
€179.99
Pietro Cozzini & Glen E Kellogg: Computational Approaches to Nuclear Receptors
Nuclear receptors (NR) are ligand-induced activated transcription factors that are involved in numerous biological processes. Since the 1990’s when the first structures were determined by means of X …
PDF
Angielski
DRM
€179.99
Manoj C. Desai & Nicholas A. Meanwell: Successful Strategies for the Discovery of Antiviral Drugs
The antiviral therapeutic area continues to rapidly generate meaningful new chemical entities; for example, for HIV alone more than 25 drugs have been approved, and in the next few years many individ …
PDF
Angielski
DRM
€214.99
Philip V Peplow & Bridget Martinez: MicroRNAs in Diseases and Disorders
From pathology to treatment, Micro RNAs in Diseases and Disorders highlights the role of micro RNAs (mi RNAs) in the development and progression of a variety of diseases, including cancer, neurologic …
EPUB
Angielski
DRM
€239.99
Philip V Peplow & Bridget Martinez: MicroRNAs in Diseases and Disorders
From pathology to treatment, Micro RNAs in Diseases and Disorders highlights the role of micro RNAs (mi RNAs) in the development and progression of a variety of diseases, including cancer, neurologic …
PDF
Angielski
DRM
€239.99
Ilona Pysz & David E. Thurston: Chemistry and Pharmacology of Anticancer Drugs
While drug therapies developed in the last 80 years have markedly improved treatment outcomes and the management of some types of cancers, the lack of effectiveness and side effects associated with t …
EPUB
Angielski
DRM
€154.37
Ilona Pysz & David E. Thurston: Chemistry and Pharmacology of Anticancer Drugs
While drug therapies developed in the last 80 years have markedly improved treatment outcomes and the management of some types of cancers, the lack of effectiveness and side effects associated with t …
PDF
Angielski
DRM
€153.84
